nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—ADORA2A—Parkinson's disease	0.812	1	CbGaD
Pentoxifylline—ADORA1—nerve—Parkinson's disease	0.00364	0.0655	CbGeAlD
Pentoxifylline—NT5E—embryo—Parkinson's disease	0.00277	0.0498	CbGeAlD
Pentoxifylline—Theobromine—ADORA2A—Parkinson's disease	0.00259	0.344	CrCbGaD
Pentoxifylline—NT5E—cardiovascular system—Parkinson's disease	0.00207	0.0373	CbGeAlD
Pentoxifylline—Dyphylline—ADORA2A—Parkinson's disease	0.00191	0.253	CrCbGaD
Pentoxifylline—ADORA2A—forebrain—Parkinson's disease	0.00175	0.0314	CbGeAlD
Pentoxifylline—NT5E—midbrain—Parkinson's disease	0.00162	0.0291	CbGeAlD
Pentoxifylline—PDE5A—forebrain—Parkinson's disease	0.00159	0.0286	CbGeAlD
Pentoxifylline—NT5E—spinal cord—Parkinson's disease	0.00158	0.0284	CbGeAlD
Pentoxifylline—ADORA1—forebrain—Parkinson's disease	0.00151	0.0271	CbGeAlD
Pentoxifylline—ADORA2A—cardiovascular system—Parkinson's disease	0.00148	0.0266	CbGeAlD
Pentoxifylline—NT5E—head—Parkinson's disease	0.0014	0.0252	CbGeAlD
Pentoxifylline—PDE5A—cardiovascular system—Parkinson's disease	0.00135	0.0242	CbGeAlD
Pentoxifylline—Caffeine—ADORA2A—Parkinson's disease	0.00133	0.177	CrCbGaD
Pentoxifylline—NT5E—nervous system—Parkinson's disease	0.00133	0.0239	CbGeAlD
Pentoxifylline—NT5E—central nervous system—Parkinson's disease	0.00128	0.023	CbGeAlD
Pentoxifylline—ADORA1—cardiovascular system—Parkinson's disease	0.00128	0.0229	CbGeAlD
Pentoxifylline—ADORA2B—head—Parkinson's disease	0.0012	0.0216	CbGeAlD
Pentoxifylline—ADORA2B—nervous system—Parkinson's disease	0.00114	0.0205	CbGeAlD
Pentoxifylline—ADORA2A—spinal cord—Parkinson's disease	0.00113	0.0202	CbGeAlD
Pentoxifylline—PDE4B—forebrain—Parkinson's disease	0.00112	0.0201	CbGeAlD
Pentoxifylline—ADORA2B—central nervous system—Parkinson's disease	0.0011	0.0197	CbGeAlD
Pentoxifylline—ADORA1—medulla oblongata—Parkinson's disease	0.00109	0.0196	CbGeAlD
Pentoxifylline—ADORA2B—cerebellum—Parkinson's disease	0.00107	0.0193	CbGeAlD
Pentoxifylline—NT5E—brain—Parkinson's disease	0.00102	0.0183	CbGeAlD
Pentoxifylline—ADORA2A—head—Parkinson's disease	0.001	0.018	CbGeAlD
Pentoxifylline—ADORA1—midbrain—Parkinson's disease	0.000996	0.0179	CbGeAlD
Pentoxifylline—ADORA1—spinal cord—Parkinson's disease	0.000972	0.0175	CbGeAlD
Pentoxifylline—PDE4A—cerebellum—Parkinson's disease	0.000956	0.0172	CbGeAlD
Pentoxifylline—ADORA2A—nervous system—Parkinson's disease	0.000949	0.0171	CbGeAlD
Pentoxifylline—ADORA2A—central nervous system—Parkinson's disease	0.000913	0.0164	CbGeAlD
Pentoxifylline—PDE5A—head—Parkinson's disease	0.000911	0.0164	CbGeAlD
Pentoxifylline—ADORA2A—cerebellum—Parkinson's disease	0.000893	0.016	CbGeAlD
Pentoxifylline—ADORA2B—brain—Parkinson's disease	0.000871	0.0157	CbGeAlD
Pentoxifylline—PDE5A—nervous system—Parkinson's disease	0.000864	0.0155	CbGeAlD
Pentoxifylline—ADORA1—head—Parkinson's disease	0.000864	0.0155	CbGeAlD
Pentoxifylline—PDE5A—central nervous system—Parkinson's disease	0.000832	0.015	CbGeAlD
Pentoxifylline—ADORA1—nervous system—Parkinson's disease	0.000819	0.0147	CbGeAlD
Pentoxifylline—PDE5A—cerebellum—Parkinson's disease	0.000813	0.0146	CbGeAlD
Pentoxifylline—PDE4B—medulla oblongata—Parkinson's disease	0.000806	0.0145	CbGeAlD
Pentoxifylline—Theobromine—CYP2E1—Parkinson's disease	0.000793	0.105	CrCbGaD
Pentoxifylline—ADORA1—central nervous system—Parkinson's disease	0.000788	0.0142	CbGeAlD
Pentoxifylline—PDE4A—brain—Parkinson's disease	0.000777	0.014	CbGeAlD
Pentoxifylline—ADORA1—cerebellum—Parkinson's disease	0.000771	0.0139	CbGeAlD
Pentoxifylline—PDE4B—midbrain—Parkinson's disease	0.000737	0.0132	CbGeAlD
Pentoxifylline—ADORA2A—brain—Parkinson's disease	0.000725	0.013	CbGeAlD
Pentoxifylline—PDE4B—spinal cord—Parkinson's disease	0.000719	0.0129	CbGeAlD
Pentoxifylline—PDE5A—brain—Parkinson's disease	0.00066	0.0119	CbGeAlD
Pentoxifylline—PDE4B—head—Parkinson's disease	0.000639	0.0115	CbGeAlD
Pentoxifylline—ADORA1—brain—Parkinson's disease	0.000626	0.0113	CbGeAlD
Pentoxifylline—PDE4B—nervous system—Parkinson's disease	0.000606	0.0109	CbGeAlD
Pentoxifylline—PDE4B—central nervous system—Parkinson's disease	0.000583	0.0105	CbGeAlD
Pentoxifylline—PDE4B—cerebellum—Parkinson's disease	0.00057	0.0102	CbGeAlD
Pentoxifylline—PDE4B—brain—Parkinson's disease	0.000463	0.00832	CbGeAlD
Pentoxifylline—Caffeine—CYP2E1—Parkinson's disease	0.000408	0.054	CrCbGaD
Pentoxifylline—Caffeine—CYP2D6—Parkinson's disease	0.000299	0.0397	CrCbGaD
Pentoxifylline—Caffeine—ABCB1—Parkinson's disease	0.000214	0.0283	CrCbGaD
Pentoxifylline—ADORA1—Signaling Pathways—GRM4—Parkinson's disease	6.67e-05	0.000534	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HTR1A—Parkinson's disease	6.64e-05	0.000531	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TAC1—Parkinson's disease	6.62e-05	0.000529	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GRM4—Parkinson's disease	6.59e-05	0.000527	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TAC1—Parkinson's disease	6.54e-05	0.000523	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—MTHFR—Parkinson's disease	6.53e-05	0.000522	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD1—Parkinson's disease	6.49e-05	0.000519	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.46e-05	0.000517	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD1—Parkinson's disease	6.41e-05	0.000513	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GFAP—Parkinson's disease	6.4e-05	0.000512	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.38e-05	0.000511	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PENK—Parkinson's disease	6.33e-05	0.000506	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GRM5—Parkinson's disease	6.33e-05	0.000506	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAG—Parkinson's disease	6.33e-05	0.000506	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD3—Parkinson's disease	6.28e-05	0.000503	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—ADRBK1—Parkinson's disease	6.27e-05	0.000501	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HTR7—Parkinson's disease	6.26e-05	0.000501	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—DRD2—Parkinson's disease	6.26e-05	0.000501	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PENK—Parkinson's disease	6.25e-05	0.0005	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAG—Parkinson's disease	6.25e-05	0.0005	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD3—Parkinson's disease	6.21e-05	0.000497	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HTR7—Parkinson's disease	6.18e-05	0.000495	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—DRD2—Parkinson's disease	6.18e-05	0.000495	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PDYN—Parkinson's disease	6.18e-05	0.000494	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—Parkinson's disease	6.13e-05	0.00049	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—MAPK8—Parkinson's disease	6.09e-05	0.000487	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—APOE—Parkinson's disease	6.08e-05	0.000486	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—DRD2—Parkinson's disease	6.07e-05	0.000485	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HTR7—Parkinson's disease	6.07e-05	0.000485	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RIT2—Parkinson's disease	6.06e-05	0.000485	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	6e-05	0.00048	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HTR2A—Parkinson's disease	5.99e-05	0.000479	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—EDN1—Parkinson's disease	5.89e-05	0.000471	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—ADRBK1—Parkinson's disease	5.87e-05	0.000469	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GFAP—Parkinson's disease	5.81e-05	0.000465	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—ADRBK1—Parkinson's disease	5.8e-05	0.000464	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PDYN—Parkinson's disease	5.79e-05	0.000463	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GRM5—Parkinson's disease	5.74e-05	0.00046	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GRK5—Parkinson's disease	5.74e-05	0.00046	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	5.74e-05	0.000459	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PDYN—Parkinson's disease	5.72e-05	0.000457	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HTR1A—Parkinson's disease	5.71e-05	0.000457	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HTR7—Parkinson's disease	5.68e-05	0.000455	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD2—Parkinson's disease	5.68e-05	0.000455	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	5.66e-05	0.000453	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—TAC1—Parkinson's disease	5.63e-05	0.00045	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HTR7—Parkinson's disease	5.62e-05	0.000449	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD2—Parkinson's disease	5.62e-05	0.000449	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGF20—Parkinson's disease	5.55e-05	0.000444	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD1—Parkinson's disease	5.52e-05	0.000441	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GFAP—Parkinson's disease	5.44e-05	0.000435	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ADORA2A—Parkinson's disease	5.38e-05	0.00043	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GRM5—Parkinson's disease	5.38e-05	0.00043	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GFAP—Parkinson's disease	5.38e-05	0.00043	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EDN1—Parkinson's disease	5.35e-05	0.000428	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—EDN1—Parkinson's disease	5.35e-05	0.000428	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD3—Parkinson's disease	5.34e-05	0.000427	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GRM5—Parkinson's disease	5.32e-05	0.000425	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	5.25e-05	0.00042	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—INS—Parkinson's disease	5.19e-05	0.000416	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR1A—Parkinson's disease	5.19e-05	0.000415	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	5.18e-05	0.000414	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HTR2A—Parkinson's disease	5.15e-05	0.000412	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GRM4—Parkinson's disease	5.15e-05	0.000412	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TAC1—Parkinson's disease	5.11e-05	0.000409	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—IL6—Parkinson's disease	5.04e-05	0.000403	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGF20—Parkinson's disease	5.04e-05	0.000403	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—EDN1—Parkinson's disease	5.01e-05	0.000401	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD1—Parkinson's disease	5.01e-05	0.000401	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—CASP3—Parkinson's disease	5e-05	0.0004	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.99e-05	0.000399	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—INSR—Parkinson's disease	4.96e-05	0.000397	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—EDN1—Parkinson's disease	4.95e-05	0.000396	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADORA2A—Parkinson's disease	4.88e-05	0.000391	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAG—Parkinson's disease	4.88e-05	0.000391	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PENK—Parkinson's disease	4.88e-05	0.000391	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EDN1—Parkinson's disease	4.86e-05	0.000389	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD3—Parkinson's disease	4.85e-05	0.000388	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HTR7—Parkinson's disease	4.83e-05	0.000387	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD2—Parkinson's disease	4.83e-05	0.000387	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	4.8e-05	0.000384	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGF20—Parkinson's disease	4.72e-05	0.000377	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGB—Parkinson's disease	4.69e-05	0.000375	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HTR2A—Parkinson's disease	4.68e-05	0.000374	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HTR2A—Parkinson's disease	4.68e-05	0.000374	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR1A—Parkinson's disease	4.67e-05	0.000373	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGF20—Parkinson's disease	4.66e-05	0.000373	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TAC1—Parkinson's disease	4.6e-05	0.000368	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—MAPK8—Parkinson's disease	4.59e-05	0.000367	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADORA2A—Parkinson's disease	4.57e-05	0.000366	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EDN1—Parkinson's disease	4.55e-05	0.000364	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	4.53e-05	0.000362	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADORA2A—Parkinson's disease	4.52e-05	0.000362	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—INSR—Parkinson's disease	4.51e-05	0.000361	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD1—Parkinson's disease	4.51e-05	0.000361	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EDN1—Parkinson's disease	4.5e-05	0.00036	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PDYN—Parkinson's disease	4.47e-05	0.000357	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR7—Parkinson's disease	4.39e-05	0.000351	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD2—Parkinson's disease	4.39e-05	0.000351	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HTR2A—Parkinson's disease	4.38e-05	0.000351	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD3—Parkinson's disease	4.37e-05	0.000349	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—COMT—Parkinson's disease	4.35e-05	0.000348	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	4.35e-05	0.000348	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	4.35e-05	0.000348	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	4.33e-05	0.000347	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HTR2A—Parkinson's disease	4.33e-05	0.000346	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	4.32e-05	0.000346	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	4.29e-05	0.000343	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	4.27e-05	0.000342	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGB—Parkinson's disease	4.26e-05	0.000341	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HTR2A—Parkinson's disease	4.25e-05	0.00034	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR1A—Parkinson's disease	4.24e-05	0.000339	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—INSR—Parkinson's disease	4.22e-05	0.000338	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GFAP—Parkinson's disease	4.2e-05	0.000336	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TAC1—Parkinson's disease	4.17e-05	0.000334	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—INSR—Parkinson's disease	4.17e-05	0.000334	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GRM5—Parkinson's disease	4.15e-05	0.000332	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD1—Parkinson's disease	4.09e-05	0.000327	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ADRBK1—Parkinson's disease	4.08e-05	0.000326	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGB—Parkinson's disease	3.99e-05	0.000319	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	3.98e-05	0.000318	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HTR2A—Parkinson's disease	3.98e-05	0.000318	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR1A—Parkinson's disease	3.97e-05	0.000317	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD3—Parkinson's disease	3.96e-05	0.000317	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD2—Parkinson's disease	3.95e-05	0.000316	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR7—Parkinson's disease	3.95e-05	0.000316	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGB—Parkinson's disease	3.94e-05	0.000315	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HTR2A—Parkinson's disease	3.93e-05	0.000315	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	3.93e-05	0.000314	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR1A—Parkinson's disease	3.92e-05	0.000314	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TAC1—Parkinson's disease	3.91e-05	0.000313	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—IL6—Parkinson's disease	3.89e-05	0.000311	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—EDN1—Parkinson's disease	3.87e-05	0.000309	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TAC1—Parkinson's disease	3.86e-05	0.000309	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD1—Parkinson's disease	3.83e-05	0.000307	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	3.81e-05	0.000305	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD1—Parkinson's disease	3.79e-05	0.000303	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD3—Parkinson's disease	3.71e-05	0.000297	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADRBK1—Parkinson's disease	3.7e-05	0.000296	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD3—Parkinson's disease	3.67e-05	0.000293	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGF20—Parkinson's disease	3.64e-05	0.000291	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR7—Parkinson's disease	3.59e-05	0.000287	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD2—Parkinson's disease	3.59e-05	0.000287	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EDN1—Parkinson's disease	3.51e-05	0.000281	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADRBK1—Parkinson's disease	3.47e-05	0.000277	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADRBK1—Parkinson's disease	3.43e-05	0.000274	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	3.38e-05	0.000271	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR7—Parkinson's disease	3.36e-05	0.000269	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD2—Parkinson's disease	3.36e-05	0.000269	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR7—Parkinson's disease	3.32e-05	0.000265	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD2—Parkinson's disease	3.32e-05	0.000265	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF2—Parkinson's disease	3.31e-05	0.000265	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—INSR—Parkinson's disease	3.26e-05	0.000261	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1R—Parkinson's disease	3.2e-05	0.000256	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EDN1—Parkinson's disease	3.16e-05	0.000253	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGB—Parkinson's disease	3.08e-05	0.000246	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR2A—Parkinson's disease	3.07e-05	0.000246	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR1A—Parkinson's disease	3.06e-05	0.000245	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TAC1—Parkinson's disease	3.02e-05	0.000241	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF2—Parkinson's disease	3e-05	0.00024	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3e-05	0.00024	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD1—Parkinson's disease	2.96e-05	0.000237	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—Parkinson's disease	2.93e-05	0.000235	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NGF—Parkinson's disease	2.9e-05	0.000232	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1R—Parkinson's disease	2.9e-05	0.000232	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EDN1—Parkinson's disease	2.87e-05	0.00023	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD3—Parkinson's disease	2.87e-05	0.000229	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ND3—Parkinson's disease	2.82e-05	0.000226	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MCCC1—Parkinson's disease	2.82e-05	0.000226	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF2—Parkinson's disease	2.81e-05	0.000225	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF2—Parkinson's disease	2.78e-05	0.000222	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR2A—Parkinson's disease	2.77e-05	0.000221	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1R—Parkinson's disease	2.72e-05	0.000218	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1R—Parkinson's disease	2.69e-05	0.000215	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EDN1—Parkinson's disease	2.69e-05	0.000215	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRBK1—Parkinson's disease	2.68e-05	0.000214	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EDN1—Parkinson's disease	2.66e-05	0.000212	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—OMD—Parkinson's disease	2.65e-05	0.000212	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TALDO1—Parkinson's disease	2.65e-05	0.000212	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NGF—Parkinson's disease	2.64e-05	0.000211	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR7—Parkinson's disease	2.59e-05	0.000207	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD2—Parkinson's disease	2.59e-05	0.000207	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOE—Parkinson's disease	2.57e-05	0.000206	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	2.52e-05	0.000201	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR2A—Parkinson's disease	2.51e-05	0.000201	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NGF—Parkinson's disease	2.47e-05	0.000198	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NGF—Parkinson's disease	2.44e-05	0.000195	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GCH1—Parkinson's disease	2.4e-05	0.000192	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR2A—Parkinson's disease	2.35e-05	0.000188	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOE—Parkinson's disease	2.33e-05	0.000187	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR2A—Parkinson's disease	2.32e-05	0.000186	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—INS—Parkinson's disease	2.2e-05	0.000176	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOE—Parkinson's disease	2.19e-05	0.000175	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF2—Parkinson's disease	2.17e-05	0.000174	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.16e-05	0.000173	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOE—Parkinson's disease	2.16e-05	0.000173	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GBA—Parkinson's disease	2.14e-05	0.000171	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—FBP1—Parkinson's disease	2.14e-05	0.000171	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—DBH—Parkinson's disease	2.14e-05	0.000171	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1R—Parkinson's disease	2.1e-05	0.000168	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EDN1—Parkinson's disease	2.08e-05	0.000166	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—INS—Parkinson's disease	1.99e-05	0.00016	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NGF—Parkinson's disease	1.91e-05	0.000153	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—INS—Parkinson's disease	1.87e-05	0.000149	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—INS—Parkinson's disease	1.85e-05	0.000148	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR2A—Parkinson's disease	1.82e-05	0.000145	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOE—Parkinson's disease	1.69e-05	0.000135	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—Parkinson's disease	1.64e-05	0.000131	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—Parkinson's disease	1.62e-05	0.00013	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—DDC—Parkinson's disease	1.57e-05	0.000126	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK8—Parkinson's disease	1.5e-05	0.00012	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—Parkinson's disease	1.48e-05	0.000119	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.48e-05	0.000119	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—Parkinson's disease	1.48e-05	0.000118	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.46e-05	0.000117	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—INS—Parkinson's disease	1.44e-05	0.000115	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—Parkinson's disease	1.39e-05	0.000111	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—Parkinson's disease	1.38e-05	0.00011	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—Parkinson's disease	1.37e-05	0.00011	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—Parkinson's disease	1.36e-05	0.000109	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK8—Parkinson's disease	1.36e-05	0.000109	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.34e-05	0.000107	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.32e-05	0.000106	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK8—Parkinson's disease	1.28e-05	0.000102	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK8—Parkinson's disease	1.26e-05	0.000101	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.26e-05	0.000101	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—Parkinson's disease	1.07e-05	8.59e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—Parkinson's disease	1.07e-05	8.53e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK8—Parkinson's disease	9.87e-06	7.89e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	9.82e-06	7.86e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CTGF—Parkinson's disease	9.64e-06	7.71e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—Parkinson's disease	9.6e-06	7.68e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	8.98e-06	7.19e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NQO1—Parkinson's disease	8.88e-06	7.11e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TH—Parkinson's disease	8.75e-06	7e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—Parkinson's disease	8.71e-06	6.97e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYCS—Parkinson's disease	8.41e-06	6.72e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—Parkinson's disease	8.16e-06	6.53e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—Parkinson's disease	8.06e-06	6.45e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—COMT—Parkinson's disease	7.44e-06	5.95e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTP1—Parkinson's disease	7.41e-06	5.93e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MAOA—Parkinson's disease	7.39e-06	5.91e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HMOX1—Parkinson's disease	7.31e-06	5.84e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCB1—Parkinson's disease	7.01e-06	5.61e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTM1—Parkinson's disease	6.81e-06	5.45e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GPX1—Parkinson's disease	6.52e-06	5.22e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—Parkinson's disease	6.3e-06	5.04e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MTHFR—Parkinson's disease	6.02e-06	4.81e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOE—Parkinson's disease	5.6e-06	4.48e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—INS—Parkinson's disease	4.79e-06	3.83e-05	CbGpPWpGaD
